Catalyst Event
Hansoh Pharmaceutical Group Company Limited (3692) · Other
From Akros SCHK HK-Korea Cosmetics Index (ASHKCOS)
4/29/2026, 12:00:00 AM
Received two clinical trial approvals from China's NMPA for its self-developed Class 1 innovative drug, HS-10522 tablets, for the treatment of uncontrolled hypertension and primary aldosteronism.
Korean Translation
자체 개발 1등급 혁신 신약 HS-10522 정제에 대해 중국 국가약품감독관리국(NMPA)으로부터 두 건의 임상시험 승인을 획득함. 해당 임상시험은 조절되지 않는 고혈압 및 원발성 알도스테론증 치료를 위한 것임.
Related Recent Events
Hanwha Corp (000880) · Trading Issue
Confirmed corporate spin-off of Hanwha Corp into a surviving Hanwha Corp and a new Hanwha Machinery & Service Holdings entity. The shareholder record date for allocation of spin-off shares is June 30, 2026, with trading suspension scheduled from June 29, 2026 to July 23, 2026.
6/30/2026, 12:00:00 AM
Samchundang Pharm Co Ltd (000250) · Other
Extraordinary shareholders' meeting to appoint a former Financial Supervisory Service (FSS) official as a new outside director on June 30, 2026. Low importance is estimated as board changes typically have minimal immediate price impact, scheduled.
6/30/2026, 12:00:00 AM
Hanwha Corp (000880) · Trading Issue
Hanwha Corp confirmed a corporate spin-off that qualifies as a trading issue affecting its own shares. An official Korea Exchange filing states Hanwha shares were scheduled for trading suspension due to the spin-off, with the originally disclosed suspension period running from 2026-06-29 to 2026-07-23 and new shares scheduled to list on 2026-07-24. Subsequent reporting after KRX preliminary relisting approval said the new spin-off company was instead targeting establishment on 2026-08-01 and KOSPI listing on 2026-08-25, indicating the July 28 to August 20 schedule in the claim is not confirmed by the sources reviewed.
6/29/2026, 12:00:00 AM
Samchundang Pharm Co Ltd (000250) · Earnings Release
Q1 2026 earnings release on May 18, 2026. Low importance is estimated as the announcement of the release date itself usually results in minimal price movement, scheduled.
5/18/2026, 12:00:00 AM
d Alba Global Co Ltd (483650) · Earnings Release
Q1 2026 earnings release scheduled. Analysts forecast strong results driven by overseas sales growth, which previously caused a 9% stock price increase in April on anticipation scheduled.
5/12/2026, 12:00:00 AM
Laopu Gold Co Ltd (6181) · Other
Ex-dividend date for the proposed 2025 final dividend of 11.95 CNY per share on 2026-05-12. Medium importance is justified by the dividend yield typically causing a >5% price adjustment, scheduled.
5/12/2026, 12:00:00 AM